Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Extended-release formulation of carbamazepine launched in U.S.

May 5, 1998

Parkinson's disease symptoms improve in Spheramine preclinical trial

May 4, 1998

Multiple mechanisms involved in neuroprotective effects of dexanabinol

May 4, 1998

Efficacy of racemic form of LY-300164 in clonic status epilepticus

May 4, 1998

Chiroscience submits NDA to FDA for Chirocaine

May 4, 1998

Bayer's potassium channel ligands for cognition disorders

May 4, 1998

Pfizer synthesizes dual ORL1 antagonists/opioid receptor agonists

May 4, 1998

First clinical results reported for NPS-1506

May 1, 1998

LY-300164 suppresses kindling-induced seizures in mice

May 1, 1998

Lamotrigine evaluated for the treatment of childhood autism

May 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...